Northern Trust’s Dimension Therapeutics, Inc DMTX Stock Holding History

Northern Trust’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-51,719	Closed	-$310K	–	4347
2017 Q3	$310K	Buy	51,719 +12,291	+31%	+$31.9K	﹤0.01%	3668
2017 Q2	$57K	Sell	39,428 -104,084	-73%	-$141K	﹤0.01%	4064
2017 Q1	$252K	Buy	143,512 +27,202	+23%	+$72.1K	﹤0.01%	3727
2016 Q4	$506K	Buy	116,310 +489	+0.4%	+$2.6K	﹤0.01%	3522
2016 Q3	$925K	Buy	115,821 +2,566	+2%	+$18.6K	﹤0.01%	3363
2016 Q2	$680K	Buy	113,255 +57,272	+102%	+$436K	﹤0.01%	3445
2016 Q1	$438K	Buy	55,983 +1,486	+3%	+$11.7K	﹤0.01%	3495
2015 Q4	$615K	Buy	+54,497	New	+$690K	﹤0.01%	3456

Northern Trust's DMTX Position: Q4 2017 in Review

Northern Trust sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 51,719 shares — an estimated $310K sold.

Northern Trust first reported a position in DMTX in Q4 2015 and held it in 8 quarters. The position peaked at $925K in Q3 2016. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

Northern Trust reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
Northern Trust sold 51,719 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $310K.
Northern Trust first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 8 quarters.
Northern Trust's Dimension Therapeutics, Inc position peaked at $925K in Q3 2016.
0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on Northern Trust's 13F filing for Q4 2017, filed 14 Feb 2018.